Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo
Open accessThe DOI matches its Crossref record.
Abstract
The dynamics of Plasmodium vivax infection is characterized by reactivation of hypnozoites at varying time intervals. The relative contribution of new P. vivax infection and reactivation of dormant liver stage hypnozoites to initiation of blood stage infection is unclear. In this study, we investigate the contribution of new inoculations of P. vivax sporozoites to primary infection versus reactivation of hypnozoites by modeling the dynamics of P. vivax infection in Thailand in patients receiving treatment for either blood stage infection alone (chloroquine), or the blood and liver stages of infection (chloroquine + primaquine). In addition, we also analysed rates of infection in a study in Papua New Guinea (PNG) where patients were treated with either artesunate, or artesunate + primaquine. Our results show that up to 96% of the P. vivax infection is due to hypnozoite reactivation in individuals living in endemic areas in Thailand. Similar analysis revealed the around 70% of infections in the PNG cohort were due to hypnozoite reactivation. We show how the age of the cohort, primaquine drug failure, and seasonality may affect estimates of the ratio of primary P. vivax infection to hypnozoite reactivation. Modeling of P. vivax primary infection and hypnozoite reactivation provides important insights into infection dynamics, and suggests that 90-96% of blood stage infections arise from hypnozoite reactivation. Major differences in infection kinetics between Thailand and PNG suggest the likelihood of drug failure in PNG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cohorts living in endemic areas of Thailand and Papua New Guinea, hypnozoite-borne infections of blood accounted for >80% of incident P. vivax parasitemias [5,6].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 31
- K Mendis, 2001, The neglected burden of Plasmodium vivax malaria, The American journal of tropical medicine and hygiene, 64, 97, 10.4269/ajtmh.2001.64.97 · DOI · Paper page
- CA Guerra, 2010, The international limits and population at risk of Plasmodium vivax transmission in 2009, PLoS neglected tropical diseases, 4, e774, 10.1371/journal.pntd.0000774 · DOI · Paper page
- PW Gething, 2012, A long neglected world malaria map: Plasmodium vivax endemicity in 2010, PLoS Negl Trop Dis, 6, e1814, 10.1371/journal.pntd.0001814 · DOI · Paper page
- LH Miller, 1994, Malaria pathogenesis, Science, 264, 1878, 10.1126/science.8009217 · DOI · Paper page
- S Kitchen, 1938, The infection of reticulocytes by Plasmodium vivax, The American Journal of Tropical Medicine and Hygiene, 1, 347, 10.4269/ajtmh.1938.s1-18.347 · doi:10.4269/ajtmh.1938.s1-18.347
- A Arnott, 2012, Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination, Malar J, 11, 14, 10.1186/1475-2875-11-14 · DOI
- JK Baird, 2008, Real-world therapies and the problem of vivax malaria, New England Journal of Medicine, 359, 2601, 10.1056/NEJMe0808729 · DOI
- I Betuela, 2012, Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1–5 years of age, Journal of Infectious Diseases, 206, 1771, 10.1093/infdis/jis580 · DOI · Paper page
- C Luxemburger, 1999, Treatment of vivax malaria on the western border of Thailand, Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 433, 10.1016/S0035-9203(99)90149-9 · DOI
- AM McCollum, 2014, Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations, Malar J, 13, 67, 10.1186/1475-2875-13-67 · DOI
- C Koepfli, 2009, Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials, Journal of Infectious Diseases, 199, 1074, 10.1086/597303 · DOI · Paper page
- V Andrianaranjaka, 2013, Activation of minority-variant Plasmodium vivax hypnozoites following artesunate + amodiaquine treatment in a 23-year old man with relapsing malaria in Antananarivo, Madagascar, Malar J, 12, 177, 10.1186/1475-2875-12-177 · DOI
- N Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, Journal of Infectious Diseases, 195, 934, 10.1086/512242 · DOI · Paper page
- M Imwong, 2007, Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites, Journal of Infectious Diseases, 195, 927, 10.1086/512241 · DOI · Paper page
- JK Baird, 2004, Primaquine therapy for malaria, Clinical infectious diseases, 39, 1336, 10.1086/424663 · DOI · Paper page
- C Koepfli, 2013, A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children, PLoS Negl Trop Dis, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
- T Adak, 1998, Studies on the Plasmodium vivax relapse pattern in Delhi, India, Am J Trop Med Hyg, 59, 175, 10.4269/ajtmh.1998.59.175 · doi:10.4269/ajtmh.1998.59.175
- NJ White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malaria journal, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- P Shute, 1976, A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period, Transactions of the Royal Society of Tropical Medicine and Hygiene, 70, 474, 10.1016/0035-9203(76)90132-2 · DOI
- AT Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings, PLoS Negl Trop Dis, 8, e2882, 10.1371/journal.pntd.0002882 · DOI · Paper page
- FCF de Araujo, 2012, Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection, PloS one, 7, e49871, 10.1371/journal.pone.0049871 · doi:10.1371/journal.pone.0049871
- M Imwong, 2012, The first Plasmodium vivax relapses of life are usually genetically homologous, Journal of Infectious Diseases, 205, 680, 10.1093/infdis/jir806 · DOI · Paper page
- P Venkatesan, 2003, Seasonality of presentation of imported Plasmodium vivax malaria in Birmingham, UK, Trans R Soc Trop Med Hyg, 97, 550, 10.1016/S0035-9203(03)80023-8 · doi:10.1016/s0035-9203(03)80023-8
- C Koepfli, 2013, A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean children, PLoS neglected tropical diseases, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
- J Xainli, 2002, Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans, The Journal of Immunology, 169, 3200, 10.4049/jimmunol.169.6.3200 · DOI
- NM Douglas, 2011, Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 52, 612, 10.1093/cid/ciq249 · DOI · Paper page
- M Mayxay, 2004, Mixed-species malaria infections in humans, Trends in parasitology, 20, 233, 10.1016/j.pt.2004.03.006 · DOI · Paper page
- JW Bennett, 2013, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria, New England Journal of Medicine, 369, 1381, 10.1056/NEJMc1301936 · DOI · Paper page
- BS Pybus, 2012, CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine, Malar J, 11, 259, 10.1186/1475-2875-11-259 · DOI
- J Sistonen, 2007, CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure, Pharmacogenetics and genomics, 17, 93, 10.1097/01.fpc.0000239974.69464.f2 · DOI · Paper page
- N von Ahsen, 2010, CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess, International journal of molecular epidemiology and genetics, 1, 310
Cited by
Plasmodium vivax in the Era of the Shrinking P. falciparum Map
Price, R. N., Commons, R. J., Battle, K. E., Thriemer, K., & Mendis, K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.03.009 · Cited by 269
Watson, J., Taylor, W. R. J., Bancone, G., Chu, C. S., Jittamala, P., & White, N. J. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006440 · Cited by 77
Charnaud, S. C., McGready, R., Herten-Crabb, A., Powell, R., Guy, A., Langer, C., Richards, J. S., Gilson, P. R., Chotivanich, K., Tsuboi, T., et al. (2016) · Scientific Reports · doi:10.1038/srep20859 · Cited by 23
Self-citationSatyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009610 · Cited by 12
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
McGready, R., J White, N., Nosten, F. H., & Collaborators, S. R. A. M. P. S. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25582.2 · Cited by 2
Self-citation
Metadata
- Authors
- Adekunle, A. I., Pinkevych, M., McGready, R., Luxemburger, C., White, L. J., Nosten, F., Cromer, D., & Davenport, M. P.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-17
- Volume
- 9
- Issue
- 3
- Pages
- e0003595
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2013411967
- Cited by
- 102
- References
- 0
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.